Search research articles
Contact Us
Filters
Showing results (71-80 of 89) with videos related to
Page
of 9
Sort By:
Trials
|
January 23, 2014
Can a combined screening/treatment programme prevent premature failure of renal transplants due to chronic rejection in patients with HLA antibodies: study protocol for the multicentre randomised controlled OuTSMART trial
Anthony Dorling, Irene Rebollo-Mesa, Rachel Hilton, et al.
Health Technology Assessment (Winchester, England)
|
June 16, 2021
Intravitreal ranibizumab versus aflibercept versus bevacizumab for macular oedema due to central retinal vein occlusion: the LEAVO non-inferiority three-arm RCT
Philip Hykin, A Toby Prevost, Sobha Sivaprasad, et al.
Open Forum Infectious Diseases
|
February 19, 2026
Understanding the Epidemiology of Malaria in Zanzibar Through Molecular and Serological Analysis of Samples Collected During Reactive Case Detection
Varun Goel, Wahida Hassan, Caroline Murphy, et al.
Trials
|
February 21, 2018
Catheter Ablation versus Thoracoscopic Surgical Ablation in Long Standing Persistent Atrial Fibrillation (CASA-AF): study protocol for a randomised controlled trial
Habib Rehman Khan, Ines Kralj-Hans, Shouvik Haldar, et al.
Nature Communications
|
April 10, 2025
Author Correction: Effect of gut microbiome modulation on muscle function and cognition: the PROMOTe randomised controlled trial
Mary Ni Lochlainn, Ruth C E Bowyer, Janne Marie Moll, et al.
Eclinicalmedicine
|
December 4, 2023
Superiority and cost-effectiveness of monthly extended-release buprenorphine versus daily standard of care medication: a pragmatic, parallel-group, open-label, multicentre, randomised, controlled, phase 3 trial
John Marsden, Mike Kelleher, Eilish Gilvarry, et al.
Nature Communications
|
February 29, 2024
Effect of gut microbiome modulation on muscle function and cognition: the PROMOTe randomised controlled trial
Mary Ni Lochlainn, Ruth C E Bowyer, Janne Marie Moll, et al.
British Journal of Pain
|
September 14, 2020
Successful and unsuccessful recruitment and retainment strategies in a UK multicentre drug trial for a rare chronic pain condition which performed above target
Jatinder Bisla, Gareth Ambler, Bernhard Frank, et al.
Trials
|
August 19, 2022
Extended-release pharmacotherapy for opioid use disorder (EXPO): protocol for an open-label randomised controlled trial of the effectiveness and cost-effectiveness of injectable buprenorphine versus sublingual tablet buprenorphine and oral liquid methadone
John Marsden, Mike Kelleher, Zoë Hoare, et al.
BMC Medicine
|
October 26, 2021
Costs and staffing resource requirements for adaptive clinical trials: quantitative and qualitative results from the Costing Adaptive Trials project
Nina Wilson, Katie Biggs, Sarah Bowden, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 89) with videos related to
Sort By:
Page
of 9
Trials
|
January 23, 2014
Can a combined screening/treatment programme prevent premature failure of renal transplants due to chronic rejection in patients with HLA antibodies: study protocol for the multicentre randomised controlled OuTSMART trial
Anthony Dorling, Irene Rebollo-Mesa, Rachel Hilton, et al.
Health Technology Assessment (Winchester, England)
|
June 16, 2021
Intravitreal ranibizumab versus aflibercept versus bevacizumab for macular oedema due to central retinal vein occlusion: the LEAVO non-inferiority three-arm RCT
Philip Hykin, A Toby Prevost, Sobha Sivaprasad, et al.
Open Forum Infectious Diseases
|
February 19, 2026
Understanding the Epidemiology of Malaria in Zanzibar Through Molecular and Serological Analysis of Samples Collected During Reactive Case Detection
Varun Goel, Wahida Hassan, Caroline Murphy, et al.
Trials
|
February 21, 2018
Catheter Ablation versus Thoracoscopic Surgical Ablation in Long Standing Persistent Atrial Fibrillation (CASA-AF): study protocol for a randomised controlled trial
Habib Rehman Khan, Ines Kralj-Hans, Shouvik Haldar, et al.
Nature Communications
|
April 10, 2025
Author Correction: Effect of gut microbiome modulation on muscle function and cognition: the PROMOTe randomised controlled trial
Mary Ni Lochlainn, Ruth C E Bowyer, Janne Marie Moll, et al.
Eclinicalmedicine
|
December 4, 2023
Superiority and cost-effectiveness of monthly extended-release buprenorphine versus daily standard of care medication: a pragmatic, parallel-group, open-label, multicentre, randomised, controlled, phase 3 trial
John Marsden, Mike Kelleher, Eilish Gilvarry, et al.
Nature Communications
|
February 29, 2024
Effect of gut microbiome modulation on muscle function and cognition: the PROMOTe randomised controlled trial
Mary Ni Lochlainn, Ruth C E Bowyer, Janne Marie Moll, et al.
British Journal of Pain
|
September 14, 2020
Successful and unsuccessful recruitment and retainment strategies in a UK multicentre drug trial for a rare chronic pain condition which performed above target
Jatinder Bisla, Gareth Ambler, Bernhard Frank, et al.
Trials
|
August 19, 2022
Extended-release pharmacotherapy for opioid use disorder (EXPO): protocol for an open-label randomised controlled trial of the effectiveness and cost-effectiveness of injectable buprenorphine versus sublingual tablet buprenorphine and oral liquid methadone
John Marsden, Mike Kelleher, Zoë Hoare, et al.
BMC Medicine
|
October 26, 2021
Costs and staffing resource requirements for adaptive clinical trials: quantitative and qualitative results from the Costing Adaptive Trials project
Nina Wilson, Katie Biggs, Sarah Bowden, et al.
Page
of 9